Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study
Rahul Parit, Sridhar Jayavel
Topics & Concepts
MedicineCase fatality rateAngiotensin-converting enzyme 2PathogenesisDiseaseCoronavirusDiabetes mellitusOutbreakInternal medicineRenin–angiotensin systemImmunologyVirologyEndocrinologyCoronavirus disease 2019 (COVID-19)EpidemiologyInfectious disease (medical specialty)Blood pressureComputational Drug Discovery MethodsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research